Erratum to: Cost-effectiveness analysis of everolimus plus exemestane versus exemestane alone for treatment of hormone receptor positive metastatic breast cancer

Vakaramoko Diaby, Georges Adunlin, Simon B. Zeichner, Kiran Avancha, Gilberto Lopes, Stefan Gluck, Alberto J. Montero

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalBreast Cancer Research and Treatment
StateAccepted/In press - Aug 28 2014
Externally publishedYes

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this